Skip to main content

Table 3 Included articles and their main Findings

From: Effects of inflammation on the kynurenine pathway in schizophrenia — a systematic review

Author, year

Sample size

Main findings

Controls

Patients

A. Immunoglobulins

 Kanchanatawan et al. 2017 [40]

40

84 clinically stable Sz outpatients

- Physiosomatic symptoms were significantly associated with IgA/IgM responses to TRYCATs, including increased IgA responses to 3 HK, picolinic acid, and xanthurenic acid and lowered IgA responses to QUIN acid and AA

 Kanchanatawan et al. 2018a [41]

40

80 Sz outpatients, 40 deficit, and 40 non-deficit patients

- Deficit schizophrenia increased TRYCAT vs. controls and non-deficit

- Both schizophrenia subgroups showed increased IgA responses to 3-OH-kynurenine

- Negative symptoms positively correlated with increased IgA responses directed against picolinic acid and inversely with anthranilic acid without significant associations between positive ones and IgA responses to TRYCATs

 Kanchanatawan et al. 2018b [42]

 Bechter et al. 2010 [43]

4100

Inpatient Sz = 39, inpatient Af = 24

- Intrathecal immune response in 9 patients (4 with schizophrenia)

- Blood-brain barrier dysfunction in 18 patients (9 of them with schizophrenia)

- Neopterin concentrations increased in 14 patients (8 of them with schizophrenia)

- Absence of any significant changes in tryptophan nor kynurenine metabolites

B. Interleukins

 Szymona et al. 2017 [44]

45

51 Sz inpatients

- KYNA/3-HK ratio and IL-4 levels decreased

- Negative correlation between IFN-α and 3-HK level

- A positive correlation between KYNA and IFN-α

 Barry et al. 2009 [45]

36

34 outpatients

- Significant higher kynurenine/tryptophan ratio in patients without significant correlation with IFN-γ values.

 Kim et al. 2009 [46]

174

71 medication-free assessed on admission and discharge after 6 weeks

At admission:

- Th1-specific IFN-γ and TNF-α, and Th2-related IL-6 were higher

- Tryptophan was significantly lower

- Th1-related IL-2 and Th2-specific IL-4 were significantly lower

- Th1/Th2 ratio ([IFN-γ]/[IL-4]) correlated positively with the tryptophan breakdown index ([kynurenine]/plasma [tryptophan])

After six weeks of treatment:

- A significant reduction of plasma IL-6 and TNF- α

- Both mean tryptophan and kynurenine levels were significantly increased

 Schwieler et al. 2015 [47]

37

23 Sz

- Correlation between IL-6 and KYNA-production

 Kegel et al. 2017 [48]

Outpatient (MZ)

Outpatient (DZ)

- Correlation between IL-8 and QUIN

- Correlation between TNF-α and QUIN

12 (2 single twins)

11 (one single twin)

C. C-reactive protein

 Wurfel et al. 2017 [49]

92

Inpatient MDD (N = 35), BD (N = 53), SzA (N = 40), acutely ill Sz (n = 21)

Sz patients versus MDD, BD and SZA subgroups showed no significant difference in KYNA/QUIN and compared to healthy controls

  1. Abbreviations: 3HK 3-OH-kynurenine, AA anthranilic acid, Af affective disorder, BPRS The Brief Psychiatric Rating Scale, CANTAB The Cambridge Neuropsychological Test Automated Battery, CDSS Calgary Depression Scale for Schizophrenia, CRP C-reactive protein, CSF cerebrospinal fluid, DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders-Text Revision, DZ dizygotic twins, FF Fibromyalgia and Chronic Fatigue Syndrome Rating Scale, GAF Global Assessment of Functioning Scale, HAM-A Hamilton Anxiety Rating Scale, HAM-D Hamilton Depression Rating Scale, ICD 10 The International Classification of Diseases Tenth Edition, IFN- interferon-, Ig immunoglobulin, IL- interleukin-, KYN Kynurenine, KYNA kynurenic acid, MDD major depressive disorder, MINI Mini-International Neuropsychiatric Interview, MZ monozygotic twins, ND not determined, PA picolinic acid, PANSS The Positive and Negative Syndrome Scale, QUIN quinolinic acid, SANS Scale for the Assessment of Negative Symptoms, SAPS Scale for the Assessment of Positive Symptoms, SCID-I/II for DSM-IV Structured Clinical Interview for Diagnostic and Statistical Manual IV Axis I/II Disorders, SDS Schedule for Deficit Syndrome, sIL-2R soluble interleukin-2 receptor, SPQ-B Schizotypal Personality Questionnaire Brief, Sz schizophrenia, SzA schizo-affective disorder, TGF-transforming growth factor, TNF­α tumor necrosis factor­α, Trp Tryptophan, TRYCATs tryptophan catabolites, XA xanthurenic acid, YMRS The Young Mania Rating Scale